Why Are Lonmin Plc, Oxford BioMedica plc & Bango plc Among Today’s Biggest Gainers?

Should you buy or sell these 3 major gainers? Lonmin Plc (LON: LMI), Oxford BioMedica plc (LON: OXB) and Bango plc (LON: BGO)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in Lonmin (LSE: LMI) have soared by over 5% today after the mining company announced the appointment of a new CFO. Barrie van der Merwe will take over on 17 May and the market seems to have welcomed this prompt decision by the company following the resignation of Simon Scott.

Clearly, this is a time of major change for Lonmin as it seeks to implement an updated strategy in response to exceptionally difficult trading conditions. As part of this, it is restructuring its business and also seeking to cut costs; both of which are likely to have a positive impact on Lonmin’s bottom line over the medium to long term. And with Lonmin having the capital through which to effect its new plan following last year’s fundraising, its future seems to be brighter than it was just a handful of months ago.

This increased confidence plus a more stable commodity price environment has led to a rise in Lonmin’s share price of 99% since the turn of the year. This rapid increase could continue, although Lonmin remains a relatively high risk play and may only be of interest to less risk averse investors.

Also rising today are shares in Oxford BioMedica (LSE: OXB), with them being up over 11% despite no significant news flow having been released by the company today. In fact, the gene therapy specialist has not released an update since 7 March when it announced a new and expanded collaboration with Immune Design Corp. Since then its shares have fallen by around 6% but looking ahead, the company has clear potential to deliver profitability.

The challenge for investors, though, is that profitability may still be a long way off. And in the meantime Oxford BioMedica is in a cash burn phase which could require further fundraisings following its £8.1m placing in February. As such, and while Oxford BioMedica has a bright long term future in a very appealing space, it may only be worth a closer look for less risk averse investors.

Meanwhile, shares in mobile payments company Bango (LSE: BGO) have risen by 12% today despite a lack of news flow. Despite this, its shares have still fallen by 60% since the turn of the year even though Bango’s full-year results have showed that it is making progress. For example, it experienced significant growth in end user spend, with the company also doubling the rate of spending through the Bango payment platform. And with a stable cost base, it seems to be well-positioned to move towards profitability.

Of course, the market seems to be somewhat downbeat on Bango’s prospects judging by its recent share price fall. While today’s upward movement could indicate a change in sentiment, it may be prudent to await confirmation of this over the medium term before piling in.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Black woman using loudspeaker to be heard
Investing Articles

A SIPP opened at birth could be worth £10m in 55 years

The SIPP is an incredible vehicle for building wealth and saving for retirement. Many Britons just don't realise how early…

Read more »

Young Caucasian woman at the street withdrawing money at the ATM
Investing Articles

2 passive income ideas for a Stocks and Shares ISA

Looking for passive income stocks in April? Here are two high-quality FTSE 250 dividend shares to consider buying for an…

Read more »

Front view of aircraft in flight.
Investing Articles

£5,000 invested in Wizz Air shares 2 days ago is now worth…

This week has been a rather good one for beaten-down Wizz Air shares. What would have happened to a £5,000…

Read more »

Road trip. Father and son travelling together by car
Investing Articles

How much do you need in an ISA for £1,000 a week in passive income?

Ben McPoland highlights a FTSE 250 stock down by more than 25% that offers good value and an attractive 5.5%…

Read more »

A row of satellite radars at night
Investing Articles

Is Elon Musk about to send this FTSE 100 stock into orbit?

This year is shaping up to be a big one for this FTSE 100 stock and part of the reason…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Up 50% in a month! Meet Quadrise, the soaring UK penny stock that offers an alternative to oil

Mark Hartley takes a closer look at a British penny stock that envisions a future less dependent on crude oil.…

Read more »

Senior couple crossing the road on a city street. They are walking with shopping bags while Christmas shopping.
Investing Articles

How much do I need in a SIPP for a £500 monthly passive income?

Looking to earn a reliable passive income from your SIPP? Royston Wild explains how this could be possible with some…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

A P/E ratio of less than 7. Is this a red-hot value share to consider now?

James Beard uses a popular tool to identify a UK share that’s potentially undervalued. But he reckons judgement is also…

Read more »